Last reviewed · How we verify
NCT03927300: MEDIA
Telemonitoring Impact by the ApTelecare Software in Dialysis Patient
trial testing Telemonitoring Software in Chronic Renal Failure in 72 participants. Completed in 11 December 2019.
17 July 2019
Quick facts
| Lead sponsor | Tmm Software |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 72 |
| Start date | 17 July 2019 |
| Primary completion | 17 July 2019 |
| Estimated completion | 11 December 2019 |
| Sites | 1 location across France |
Drugs / interventions tested
- Telemonitoring Software
Conditions studied
- Chronic Renal Failure — all drugs for Chronic Renal Failure →
- Dialysis Related Complication — all drugs for Dialysis Related Complication →
Sponsor
Tmm Software
Who can join
18 and older, any sex, with Chronic Renal Failure or Dialysis Related Complication. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators proposed to conduct a retrospective study to evaluate the impact of the implementation of apTeleCare software on the management of dialysis patients at home in terms of the number and duration of hospitalizations. For this purpose, the investigators will compare patients' data over a 2-year interval before the introduction of Telemonitoring (January 2012 and December 2013 inclusive - Group 1) with patients data who have benefited from this application (between August 2016 and July 2018).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03927300
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chronic Renal Failure
Currently open trials in the same condition.
- NCT06227468 — A Clinical Study to Map the HLA Genomic Region in the Greek Population · recruiting
- NCT06347029 — Evaluation of Endothelial Dysfunction Using the "Flow Mediated Dilation" Test in a Population of Chronic Renal Failure P · NA · recruiting
- NCT05884866 — A Study to Investigate the Mechanistic Effects of Dapagliflozin Alone or in Combination With Balcinrenone, Compared to B · Phase 2 · recruiting
- NCT05353946 — Coronary Rotational Atherectomy Elective vs. Bailout in Severely Calcified Lesions and Chronic Renal Failure · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03927300 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tmm Software
- Last refreshed: 10 March 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03927300.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing